DNA sequencing for confirmation of rifampin resistance detected by cepheid xpert MTB/RIF assay

16Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

DNA sequencing of rpoB and culture-based drug susceptibility results were evaluated for samples referred for confirmation of rifampin resistance detected by the Cepheid Xpert MTB/RIF assay. Silent mutations and mutations associated with low-level resistance were found in the study population. These data support CDC recommendations to confirm Xpert rifampin resistance results.

Cite

CITATION STYLE

APA

McAlister, A. J., Driscoll, J., & Metchock, B. (2015). DNA sequencing for confirmation of rifampin resistance detected by cepheid xpert MTB/RIF assay. Journal of Clinical Microbiology, 53(5), 1752–1753. https://doi.org/10.1128/JCM.03433-14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free